Elisabetta Bolli

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Induced Apoptosis

Endoplasmic Reticulum Stress

Combination Therapy

Cancer Stem Cells

Top Venues

International journal of molecular sciences

University of Turin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Turin

Italy

Research Fellow :: Department of Molecular Biotechnology and Health Sciences

Publications

Giuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, Chiara Galiazzi, Elisabetta Bolli, Laura Conti, Federica Cavallo
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models. Biomedicines 10 (11) (2022)
Antonino Di Lorenzo, Elisabetta Bolli, Roberto Ruiu, Giuseppe Ferrauto, Enza Di Gregorio, Lidia Avalle, Aurora Savino, Pietro Poggio, Irene Fiore Merighi, Federica Riccardo, Mara Brancaccio, Federica Cavallo, Federica Cavallo, Laura Conti
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Oncoimmunology 11 (1) (2022)
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, Federica Cavallo, Laura Conti
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. International journal of molecular sciences 21 (24) (2020)
Gaetano Donofrio, Giulia Tebaldi, Stefania Lanzardo, Roberto Ruiu, Elisabetta Bolli, Andrea Ballatore, Valeria Rolih, Francesca Macchi, Laura Conti, Federica Cavallo
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells. Oncoimmunology 7 (12) (2018)